Nasdaq
EUROPEAN COMMISSION APPROVES MARKETING AUTHORISATION FOR VELTASSA®
21-07-2017
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vifor Pharma Ltd. via GlobeNewswire
HUG#2122148